Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June–October 2020: A Population-Based Survey
Jannae C. Parrott, Ariana N. Maleki, Valerie E Vassor, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 2, pp. 188-195
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications
Andrew Levin, Nana Owusu‐Boaitey, Sierra Pugh, et al.
BMJ Global Health (2022) Vol. 7, Iss. 5, pp. e008477-e008477
Open Access | Times Cited: 161
Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission, and death: a global systematic review and meta-analysis of over 200 million study participants
Patricia Irizar, Daniel Pan, Dharmi Kapadia, et al.
EClinicalMedicine (2023) Vol. 57, pp. 101877-101877
Open Access | Times Cited: 56
Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022
Ryan E. Wiegand, Yangyang Deng, Xiaoyi Deng, et al.
The Lancet Regional Health - Americas (2022) Vol. 18, pp. 100403-100403
Open Access | Times Cited: 44
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020
Preeti Pathela, Addie Crawley, Don Weiss, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 2, pp. 196-206
Open Access | Times Cited: 51
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021
Alexia Couture, B. Casey Lyons, Megha Mehrotra, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 3
Open Access | Times Cited: 23
Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022
Sharon K. Greene, Alison Levin‐Rector, Nang Thu Thu Kyaw, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 19
Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study
Nana Owusu‐Boaitey, Timothy Russell, Gideon Meyerowitz‐Katz, et al.
Eurosurveillance (2023) Vol. 28, Iss. 21
Open Access | Times Cited: 8
The role of socio-economic disparities in the relative success and persistence of SARS-CoV-2 variants in New York City in early 2021
Tetyana I. Vasylyeva, Jennifer L. Havens, Jade Wang, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012288-e1012288
Open Access | Times Cited: 2
The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York
Joseph L. Simonson, Christine Tanaka Esposito, T. Frantzen, et al.
Journal of Cystic Fibrosis (2022) Vol. 21, Iss. 3, pp. e176-e183
Open Access | Times Cited: 11
COVID-19 SeroHub, an online repository of SARS-CoV-2 seroprevalence studies in the United States
Neal D. Freedman, Liliana Brown, Lori Newman, et al.
Scientific Data (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 9
Adapting Survey Data Collection to Respond to the COVID-19 Pandemic: Experiences From a Local Health Department
Amber Levanon Seligson, Karen A. Alroy, M.L. Sanderson, et al.
American Journal of Public Health (2021) Vol. 111, Iss. 12, pp. 2176-2185
Open Access | Times Cited: 12
The Longitudinal Analysis of Convergent Antibody VDJ Regions in SARS-CoV-2-Positive Patients Using RNA-Seq
Kate J. Liu, Monika A. Zelazowska, Kevin M. McBride
Viruses (2023) Vol. 15, Iss. 6, pp. 1253-1253
Open Access | Times Cited: 4
SARS-CoV-2 pandemic in New York metropolitan area: the view from a major urgent care provider
Madhura S. Rane, Angela Profeta, Emily Poehlein, et al.
Annals of Epidemiology (2022) Vol. 74, pp. 31-40
Open Access | Times Cited: 7
The role of housing characteristics in racial and ethnic disparities in SARS-CoV-2 antibody seropositivity among New York City adults: A population representative study
Isabel Gouse, Sarah Walters, Sara A. Miller‐Archie, et al.
Preventive Medicine (2022) Vol. 164, pp. 107287-107287
Open Access | Times Cited: 7
Assessment of SARS-CoV-2 Seroprevalence by Community Survey and Residual Specimens, Denver, Colorado, July–August 2020
Kiersten J. Kugeler, Laura Jean Podewils, Nisha B. Alden, et al.
Public Health Reports (2021) Vol. 137, Iss. 1, pp. 128-136
Open Access | Times Cited: 8
Socioeconomic Disparities in Severe Acute Respiratory Syndrome Coronavirus 2 Serological Testing and Positivity in New York City
Wil Lieberman‐Cribbin, Marta Galanti, Jeffrey Shaman
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 12
Open Access | Times Cited: 6
Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020–March 2021
Jannae C. Parrott, Ariana Maleki Annibale, Sukhminder Osahan, et al.
Epidemiology and Infection (2022) Vol. 150
Open Access | Times Cited: 3
COVID-19 Knowledge Among Sexual and Gender Minority Adults in New York City
Connor Wright, Jessamyn Bowling, Joey Platt, et al.
LGBT Health (2024)
Closed Access
Impact of Age and Comorbid Conditions on Incidence Rates of COVID‐19‐Associated Hospitalizations, 2020–2021
Lisa Saiman, Edward E. Walsh, Angela R. Branche, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 11
Open Access
Disparities in anti-nucleocapsid and anti-spike SARS-CoV-2 antibody prevalence in NYC — April–October 2021
Anne Schuster, Erik Kopping, Jo-Anne Caton, et al.
Annals of Epidemiology (2024)
Open Access
Severe respiratory viral infections in children with history of asymptomatic or mild COVID‐19
Nooralam Rai, Joseph A. Cornett, Philip Zachariah, et al.
Pediatric Pulmonology (2021) Vol. 57, Iss. 2, pp. 361-366
Open Access | Times Cited: 4
Pfizer-BioNTech Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Long-term Care Facility Staff With and Without Prior Infection in New York City, January–June 2021
Kathryn Peebles, Robert J. Arciuolo, Anthony Romano, et al.
The Journal of Infectious Diseases (2023) Vol. 227, Iss. 4, pp. 533-542
Open Access | Times Cited: 1
Estimation of SARS-CoV-2 Seroprevalence in Central North Carolina: Accounting for Outcome Misclassification in Complex Sample Designs
Nishma P. Vias, Caitlin A. Cassidy, Jessie K. Edwards, et al.
Epidemiology (2023) Vol. 34, Iss. 5, pp. 721-731
Open Access | Times Cited: 1
Missing science: A scoping study of COVID-19 epidemiological data in the United States
Rajiv Bhatia, Isabella Sledge, Stefan Baral
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0248793-e0248793
Open Access | Times Cited: 2
Assessment of COVID-19 hospitalization risk during SARS-CoV-2 Omicron relative to Delta variant predominance, New York City, August 2021–January 2022
Sharon K. Greene, Alison Levin‐Rector, Elizabeth Luoma, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top